Lisata Therapeutics (LSTA) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$561.7 million.
- Lisata Therapeutics' Retained Earnings fell 335.67% to -$561.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$561.7 million, marking a year-over-year decrease of 335.67%. This contributed to the annual value of -$548.1 million for FY2024, which is 378.45% down from last year.
- According to the latest figures from Q3 2025, Lisata Therapeutics' Retained Earnings is -$561.7 million, which was down 335.67% from -$557.4 million recorded in Q2 2025.
- Over the past 5 years, Lisata Therapeutics' Retained Earnings peaked at -$513.4 million during Q1 2023, and registered a low of -$561.7 million during Q3 2025.
- Over the past 3 years, Lisata Therapeutics' median Retained Earnings value was -$538.5 million (recorded in 2024), while the average stood at -$537.9 million.
- Per our database at Business Quant, Lisata Therapeutics' Retained Earnings plummeted by 407.2% in 2024 and then crashed by 335.67% in 2025.
- Lisata Therapeutics' Retained Earnings (Quarter) stood at -$528.1 million in 2023, then fell by 3.78% to -$548.1 million in 2024, then fell by 2.49% to -$561.7 million in 2025.
- Its Retained Earnings stands at -$561.7 million for Q3 2025, versus -$557.4 million for Q2 2025 and -$552.8 million for Q1 2025.